Home > Coller Institute News > $12,000 Distributed in CIV 2017 Venture Research Awards 科勒风投研究院2017研究奖——获奖者

$12,000 Distributed in CIV 2017 Venture Research Awards 科勒风投研究院2017研究奖——获奖者



Tel Aviv, Israel – CIV’s research awards aim to encourage and celebrate academic research in the field of venture with the goal of making a significant contribution to understanding and shaping the venture ecosystem. These awards and the Institute may provide the winners with a unique platform to discuss and disseminate their work, including participation in our future events.

The call for awards was published through various CIV channels, on the social networks, through university research authorities and academic networks (e.g., SSRN, WikiCFP, etc.). During the submission period (1-Dec-2016 – 31-Jan-2017), a total of 36 new papers were submitted to the competition. All the papers were independently reviewed by two judges – Prof. Eli Talmor (London Business School) and Prof. Yesha Sivan (Coller Institute of Venture), and the winners were decided according to their reviews.

On February 20, 2017, CIV awarded one Grand Prize and two Runner-up awards. We hereby announce the winners as follows:

Grand Prize:

Massimiliano Guerini
Politecnico di Milano, Milan, Italy

Governmental venture capital in Europe: Screening and certification
co-authored with Anita Quas, EMLyon Business School

$10,000 Award

Runner-Up Awards:

Serden Ozcan
WHU – Otto Belsheim School of Management, Vallendar, Germany

The Gift of Inheritance: How Voluntary Turnover in Venture Capital Firms Affects the Performance of Portfolio Start-ups
co-authored with Dirk Sassmannshausen, WHU

$1,000 Award

Hung-Chia Scott Hsu
Sam M. Walton Business School, University of Arkansas

Investment Allocation in Venture Capital Funds
co-authored with Vikram Nanda, UT Dallas, and Qinghai Wang, University of Central Florida

$1,000 Award

The winning papers will be published soon as guest posts.

The awards ceremony will take place at the CIV2017HK conference in Hong Kong, on April 23, 2017.

The winning papers will be presented during the CIV2017HK academic papers session at the Chinese University of Hong Kong, on April 22, 2017

Please click here to attend the event.

Would you like to receive updates on future calls for awards and grants? Become a CIV member

Check Also

Structured Exits: A Potential New Source of Funding for Life Science Startups A Guest Post by Leslie Mitts

Structured exits are an important funding structure for new ventures. Rather than relying solely on the upside from an exit, structured exits can rely on the venture’s anticipated cash flow, or percentage of milestone payments, to repay the investor. For investors, they can offer reduced risk with the possibility of an upside; for ventures, they provide a new source of growth capital and less dilution. For life-sciences companies caught in the “death valley” between seed grants and venture capital eligibility, structured exits - carefully adapted and applied - can be a new alternative or complement to bridge loans, incubators, strategic investors, and non-dilutive funding from government sources. Read more in a guest post by Leslie Mitts, featuring Att. David Gitlin, on the CIV website.